VAN ECK ASSOCIATES CORP - ENZYMOTEC LTD ownership

Quarter-by-quarter ownership
VAN ECK ASSOCIATES CORP ownership history of ENZYMOTEC LTD
ValueSharesWeighting
Q4 2017$41,000
-42.3%
3,476
-43.8%
0.00%
Q3 2017$71,000
+47.9%
6,180
+4.7%
0.00%
Q2 2017$48,000
-42.2%
5,904
-37.6%
0.00%
Q1 2017$83,000
+33.9%
9,4640.0%0.00%
Q4 2016$62,000
-30.3%
9,464
-25.5%
0.00%
Q3 2016$89,000
-16.0%
12,705
+0.4%
0.00%
-100.0%
Q2 2016$106,000
-1.9%
12,659
+5.9%
0.00%0.0%
Q1 2016$108,000
-6.9%
11,953
+0.6%
0.00%0.0%
Q4 2015$116,000
-5.7%
11,884
-12.9%
0.00%0.0%
Q3 2015$123,00013,6390.00%
Other shareholders
ENZYMOTEC LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Gagnon Advisors, LLC 130,313$2,404,0001.99%
TIGER MANAGEMENT L.L.C. 677,548$4,438,0000.80%
Paulson & Co. 4,205,980$27,549,0000.35%
ALGERT GLOBAL LLC 50,566$331,0000.10%
GAGNON SECURITIES LLC 377,302$194,0000.08%
MENTA CAPITAL LLC 49,029$321,0000.03%
ACADIAN ASSET MANAGEMENT LLC 229,862$1,506,0000.01%
Laurion Capital Management LP 109,913$720,0000.01%
GSA CAPITAL PARTNERS LLP 11,300$74,0000.00%
Tower Research Capital LLC (TRC) 4,831$32,0000.00%
View complete list of ENZYMOTEC LTD shareholders